Raging real estate prices have sent investors pouring into exchange-traded funds tracking the industry’s gains.
Health stocks roared on Tuesday as investors flocked back to high-flying biotechnology companies and diagnostics firms who have developed tests to track Covid-19.
Gold rose to an eight-week high as the dollar weakened with traders awaiting results from key elections in Georgia and weighing surging coronavirus cases. Platinum and palladium surged.
Medical-device makers are charging into 2021 poised for a fresh blast of deal making with soaring share prices and piles of cash at the ready.
State Street’s SPDR S&P 500 ETF Trust (SPY) just added $9.8 billion in a single day, according to data compiled by Bloomberg.
As the brutal technology rout deepens, exchange-traded fund investors are placing bets on value.
Gold advanced to a fresh record beyond $2,000 an ounce as investors assessed increased geopolitical risks and the prospect for further stimulus to combat fallout from the coronavirus pandemic.
Vanguard Group’s U.S. exchange-traded funds attracted inflows of about $89 billion in the first half, surging ahead of industry leader BlackRock Inc. in a volatile period.
One of Wall Street’s hottest innovations is being hailed as the potential key to luring trillions of actively managed dollars to the booming market for exchange-traded funds. Yet two of the industry’s biggest players want no part of it for now.
Gold headed toward the highest since 2012, supported by concerns over a second wave of coronavirus infections and ongoing expectations of a flood of stimulus measures.
Investors should be prepared for the possibility that the economy and markets might recover quicker than is currently priced in, according to Credit Suisse Group AG.